Global Nanomaterials In Personalized Medicine Market
Pharmaceuticals

A major growth driver for the Nanocarriers Market is the increasing demand for personalized medicine supported by advancements in genomics and targeted therapies

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Nanomaterials In Personalized Medicine Market In 2026 And What Value Is Projected For 2030?

The market size for nanomaterials in personalized medicine has expanded quickly in recent years. It is anticipated to increase from $392.97 billion in 2025 to $438.79 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.7%. Historically, this growth can be ascribed to progress in genomics and molecular biology, the wider acceptance of targeted therapies, the broadening of translational medical research, the accessibility of advanced nanofabrication techniques, and the growth of academic-industry collaborations.

The nanomaterials in personalized medicine market is set to experience significant expansion in the coming years. It is projected to reach $674.28 billion by 2030, expanding at a compound annual growth rate (CAGR) of 11.3%. This growth during the forecast period can be attributed to several factors, including the increasing demand for personalized healthcare solutions, rising investment in precision medicine programs, the expanding use of nanomaterials in diagnostics and imaging, a growing focus on minimizing therapy side effects, and ongoing innovation in nano-enabled medical technologies. Major trends expected during this period include the increasing use of targeted nanomaterials for individualized therapies, the growing integration of molecular diagnostics with nanotechnology, rising adoption of nanomaterials in precision drug delivery, the expansion of nanotechnology into regenerative medicine, and an enhanced focus on patient-specific treatment outcomes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp

What Major Drivers Are Influencing Demand In The Nanomaterials In Personalized Medicine Market?

The growing need for personalized medicine is projected to stimulate the expansion of the nanomaterials in personalized medicine market moving forward. Personalized medicine is a medical strategy focused on tailoring treatments for individual patients by considering their genetic, environmental, and lifestyle elements to optimize results and elevate care quality. The rising demand for personalized medicine is attributed to breakthroughs in genomic technologies, which facilitate the accurate identification of genetic variations and the creation of customized treatments for individuals. Nanomaterials are instrumental in personalized medicine, enhancing it by enabling targeted and patient-specific therapies, thereby boosting treatment effectiveness and safety. These materials facilitate the precise delivery of drugs, genes, or RNA, which helps in minimizing side effects and optimizing therapeutic outcomes. For instance, in February 2024, as reported by the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) cleared 26 new personalized medicines in 2023, a considerable increase from the 12 approved in 2022. Thus, the escalating demand for personalized medicine is a key factor driving the growth of the nanomaterials in personalized medicine market.

What Are The Key Segments Of The Nanomaterials In Personalized Medicine Market?

The nanomaterials in personalized medicine market covered in this report is segmented –

1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles

2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery

3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods

4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines

5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions

Subsegments:

1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots

2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles

3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels

4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods

5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles

What Key Trends Are Influencing The Development Of The Nanomaterials In Personalized Medicine Market?

Leading firms within the nanomaterials in personalized medicine sector are prioritizing strategic collaborations with the aim of speeding up clinical development, broadening therapeutic uses, and reducing the time required to bring products to market, all while adhering to changing regulatory requirements. These partnerships involve companies or organizations pooling their specialized knowledge and assets to quicken the pace of innovation and broaden prospects within personalized medicine. An illustrative example occurred in May 2025, when Acuitas Therapeutics Inc., a biotechnology firm based in Canada, partnered with Integrated DNA Technologies Inc., a genomics solutions provider from the US. Together, they introduced a method for delivering personalized CRISPR gene-editing therapy, leveraging their lipid nanoparticles platform, which successfully treated one infant suffering from a rare genetic condition. This approach incorporated accurately targeted CRISPR payloads, custom-tailored dose adjustments, and swift bespoke formulation. Such a breakthrough streamlines highly individualized, single-occurrence treatments, thereby enhancing therapeutic accuracy and improving patient results. However, it also introduces complexities concerning large-scale manufacturing, precise regulatory customization, and the production of extremely small volumes.

Who Are The Leading Companies Operating In The Nanomaterials In Personalized Medicine Market?

Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.

Read the full nanomaterials in personalized medicine market report here:

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-personalized-medicine-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Nanomaterials In Personalized Medicine Market?

North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nanomaterials In Personalized Medicine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28276&type=smp

Browse Through More Reports Similar to the Global Nanomaterials In Personalized Medicine Market 2026, By The Business Research Company

Nanomaterials In Cosmetic And Personal Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-cosmetic-and-personal-care-global-market-report

Nanomedicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Healthcare Nanotechnology Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model